3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Neutropenia
5
Breast Neoplasms
5
Febrile Neutropenia
3
Wilms Tumor
1
Uterine Cervical Neoplasms
1
Sarcoma, Ewing
1
Sarcoma, Clear Cell
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Retinoblastoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Osteosarcoma
1
Neuroblastoma
1
Neoplasms, Germ Cell and Embryonal
1
Malignant Solid Tumors
1
Lymphoma
1
Leukemia, Myeloid, Acute
1
Hepatoblastoma
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Breastcancer
1
Breast Cancer Female
1
Interventions
Cyclophosphamide
56
Etoposide
40
Filgrastim
37
Carboplatin
34
Vincristine
30
Doxorubicin
30
Melphalan
27
Topotecan
25
Isotretinoin
24
Peripheral Blood Stem Cell Transplantation
23
Granulocyte Colony-Stimulating Factor
22
Cisplatin
21
Irinotecan
20
sargramostim
18
Temozolomide
17
humanized 3F8 anti-GD2 monoclonal antibody
15
Radiotherapy
15
3-Iodobenzylguanidine
13
Granulocyte-Macrophage Colony-Stimulating Factor
11
Busulfan
11
dinutuximab
10
Interleukin-2
9
aldesleukin
8
Thiotepa
8
Ifosfamide
8
etoposide phosphate
7
Mesna
7
Vorinostat
6
Stem Cell Transplantation
6
Polymerase Chain Reaction
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Neuroblastoma
×
pegylated granulocyte colony-stimulating factor
×
Clear all
NCT02390843
2020-04-03
AflacST1402
Emory University
Phase 1
Completed
13 enrolled